Genetically engineered mesenchymal stromal cells producing TNFα have tumour suppressing effect on human melanoma xenograft

Abstract

The results of the present study demonstrate that tumour cells respond to hTNFα-based treatment mediated by genetically engineered AT-MSC/hTNFα both in vitro and in vivo.